class name | count |
---|---|
rosids | 22 |
asterids | 14 |
Magnoliophyta | 12 |
Euphyllophyta | 7 |
eudicotyledons | 7 |
Spermatophyta | 4 |
Liliopsida | 4 |
class name | count |
---|---|
Lauraceae
![]() |
12 |
Rubiaceae
![]() |
8 |
Polygonaceae
![]() |
7 |
Ericaceae
![]() |
4 |
Davalliaceae
![]() |
4 |
Hippocastanaceae
![]() |
4 |
Pinaceae
![]() |
4 |
Rhizophoraceae
![]() |
3 |
Vitaceae
![]() |
3 |
Rosaceae
![]() |
3 |
Gleicheniaceae
![]() |
3 |
Fabaceae
![]() |
2 |
Anacardiaceae
![]() |
2 |
Dioscoreaceae
![]() |
2 |
Arecaceae
![]() |
2 |
Apocynaceae
![]() |
2 |
Malpighiaceae
![]() |
1 |
Malvaceae
![]() |
1 |
Euphorbiaceae
![]() |
1 |
Celastraceae
![]() |
1 |
br08003 Category | # of metabolite |
---|---|
Proanthocyanidins | 1 |
br08003 Category | KEGG ID | KNApSAcK ID |
---|---|---|
Proanthocyanidins | C10222 | C00002918 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00002918
![]() |
Epicatechin-(4beta->8)5-epicatechin
|
![]() |
||||
C00009066
![]() |
[3,5,7,4'-Tetrahydroxyflavan-(4->8)]3-3,4,5,7,4'-pentahydroxyflavan
|
![]() |
||||
C00009101
![]() |
Kandelin B3
|
![]() |
||||
C00009102
![]() |
Davallin
|
C073481
|
![]() |
|||
C00009103
![]() |
Epicatechin-(4beta->6)-epicatechin-(4beta->8)-epicatechin-(4beta->6)-epicatechin
|
![]() |
||||
C00009104
![]() |
Catechin-(4alpha->6)-[epicatechin-(4beta->8)]2-epicatechin
|
![]() |
||||
C00009105
![]() |
[Epicatechin-(4beta->8)]2-epicatechin-(4beta->6)-catechin
|
![]() |
||||
C00009106
![]() |
Arecatannin A2
|
![]() |
||||
C00009107
![]() |
Cinnamtannin A1
|
![]() |
||||
C00009108
![]() |
[Epicatechin-(4beta->8)]4-catechin
|
CHEMBL592373
|
2 / 3 / 4 |
![]() |
||
C00009109
![]() |
[Epicatechin-(4beta->8)]4-epicatechin
|
CHEMBL592373
|
2 / 3 / 4 |
![]() |
||
C00009122
![]() |
[Epigallocatechin-(4->8)]3-epigallocatechin
|
![]() |
||||
C00009155
![]() |
Fisetinidol-(4alpha->6)-fisetinidol-(4alpha->8)-catechin-(6->4alpha)-fisetinidol
|
![]() |
||||
C00009156
![]() |
Fisetinidol-(4beta->6)-fisetinidol-(4beta->8)-catechin-(6->4alpha)-fisetinidol
|
![]() |
||||
C00009157
![]() |
ent-Fisetinidol-(4alpha->6)-ent-fisetinidol-(4alpha->8)-catechin-(6->4alpha)-ent-fisetinidol
|
![]() |
||||
C00009158
![]() |
ent-Fisetinidol-(4beta->6)-ent-fisetinidol-(4beta->8)-catechin-(6->4alpha)-ent-fisetinidol
|
![]() |
||||
C00009187
![]() |
Kandelin B1
/ Cinchonain-1a-(4beta->8)-epicatechin-(4beta->8)-epicatechin |
![]() |
||||
C00009188
![]() |
Kandelin B4
/ Cinchonain-1b-(4beta->8)-epicatechin-(4beta->8)-catechin |
![]() |
||||
C00009220
![]() |
[3-O-Galloylepicatechin-(4beta->6)]2-epicatechin-3-O-gallate
|
![]() |
||||
C00009221
![]() |
3-O-Galloylepicatechin-(4beta->6)-3-O-galloylepicatechin-(4beta->8)-catechin
|
![]() |
||||
C00009222
![]() |
3-O-Galloylepicatechin-(4beta->6)-3-O-galloylepicatechin-(4beta->8)-epicatechin-3-O-gallate
|
![]() |
||||
C00009223
![]() |
3-O-Galloylepicatechin-(4beta->8)-3-O-galloylepicatechin-(4beta->6)-catechin
|
![]() |
||||
C00009224
![]() |
[Epicatechin-(4beta-8)]2-epicatechin-3-O-gallate
|
![]() |
||||
C00009225
![]() |
Epicatechin-(4beta->8)-3-O-galloylepicatechin-(4beta->8)-catechin
|
![]() |
||||
C00009226
![]() |
[3-Galloylepicatechin-(4beta->8)]2-catechin
|
![]() |
||||
C00009227
![]() |
3-O-Galloylepicatechin-(4beta->8)-3-O-galloyl-ent-epicatechin-(4alpha->8)-ent-epicatechin
|
![]() |
||||
C00009228
![]() |
Epicatechin-(4beta->8)-3-O-galloylepicatechin-(4beta->8)-epicatechin-3-O-gallate
|
![]() |
||||
C00009229
![]() |
[3-O-Galloylepicatechin-(4beta->8)]2-epicatechin-3-O-gallate
|
CHEMBL262261
CHEMBL386276 |
11 / 2 / 2 |
![]() |
||
C00009244
![]() |
Epicatechin-(4beta->8)-catechin-(4alpha->8)-catechin-3-O-(1-hydroxy-6-oxo-2-cyclohexene-1-carboxylate)
|
![]() |
||||
C00009271
![]() |
Pavetannin C4
|
![]() |
||||
C00009272
![]() |
Pavetannin C5
|
![]() |
||||
C00009273
![]() |
Epiafzelechin-(4beta->8)-epicatechin-(2beta->7,4beta->8)-epicatechin-(4beta->8)-epicatechin
|
![]() |
||||
C00009302
![]() |
Epicatechin-(2beta->7,4beta->8)-epicatechin-(4beta->8)-epicatechin-(4beta->6)-catechin
|
![]() |
||||
C00009303
![]() |
Epicatechin-(2beta->7,4beta->8)-[epicatechin-(4beta->8)]2-catechin
|
![]() |
||||
C00009304
![]() |
Pavetannin C2
|
![]() |
||||
C00009305
![]() |
Pavetannin C3
|
![]() |
||||
C00009306
![]() |
Pavetannin C 1
|
CHEMBL1213877
|
![]() |
|||
C00009307
![]() |
Cinnamtannin D2
|
CHEMBL410924
CHEMBL411351 CHEMBL502146 |
11 / 2 / 2 |
![]() |
||
C00009308
![]() |
Cinnamtannin B2
|
CHEMBL410924
CHEMBL411351 CHEMBL502146 |
11 / 2 / 2 |
![]() |
||
C00009309
![]() |
Aesculitannin G
|
![]() |
||||
C00009310
![]() |
Pavetannin D 1
|
![]() |
||||
C00009311
![]() |
[Epicatechin-(4beta->8)]2-epicatechin-(2beta->7,4beta->8)-epicatechin-(4beta->8)-epicatechin
|
![]() |
||||
C00013284
![]() |
Aesculitannin E
/ (+)-Aesculitannin E |
![]() |
||||
C00013285
![]() |
Parameritannin A1
/ (2R,3R,4S,8S,14R,15R)-2,8-bis(3,4-Dihydroxyphenyl)-6-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-3,5,7-trihydroxy-2H-1-benzopyran-4-yl]-4-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-3,5,7-trihydroxy-2H-1-benzopyran-8-yl]-3,4-dihydro-8,14-methano-2H,14H-1-benzopyrano[7,8-d][1,3]benzodioxocin-3,5,11,13,15-pentol |
CHEMBL1213878
CHEMBL1823107 |
1 / 0 / 3 |
![]() |
||
C00033288
![]() |
Parameritannin A2
|
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q15139 | Serine/threonine-protein kinase D1 | Pkd | C00009229 C00009307 C00009308 | 0 / 0 |
P41743 | Protein kinase C iota type | Iota | C00009229 C00009307 C00009308 | 0 / 0 |
P24723 | Protein kinase C eta type | Eta | C00009229 C00009307 C00009308 | 1 / 0 |
Q05513 | Protein kinase C zeta type | Iota | C00009229 C00009307 C00009308 | 0 / 0 |
Q04759 | Protein kinase C theta type | Delta | C00009229 C00009307 C00009308 | 0 / 1 |
Q02156 | Protein kinase C epsilon type | Eta | C00009229 C00009307 C00009308 | 0 / 0 |
O94806 | Serine/threonine-protein kinase D3 | Pkd | C00009229 C00009307 C00009308 | 0 / 0 |
P05771 | Protein kinase C beta type | Alpha | C00009229 C00009307 C00009308 | 0 / 0 |
Q05655 | Protein kinase C delta type | Delta | C00009229 C00009307 C00009308 | 0 / 0 |
P05129 | Protein kinase C gamma type | Alpha | C00009229 C00009307 C00009308 | 1 / 1 |
P17252 | Protein kinase C alpha type | Alpha | C00009229 C00009307 C00009308 | 0 / 0 |
P08253 | 72 kDa type IV collagenase | M10A | C00009108 C00009109 | 1 / 3 |
P14780 | Matrix metalloproteinase-9 | M10A | C00009108 C00009109 | 2 / 2 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00013285 | 0 / 3 |
OMIM | preferred title | UniProt |
---|---|---|
#603932 | Intervertebral disc disease; idd |
P14780
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#605361 | Spinocerebellar ataxia 14; sca14 |
P05129
|
#601367 | Stroke, ischemic |
P24723
|
KEGG | name | UniProt |
---|---|---|
H00063 | Spinocerebellar ataxia (SCA) |
P05129
(related)
|
H00025 | Penile cancer |
P08253
(related)
P14780 (related) P35354 (related) |
H00028 | Choriocarcinoma |
P08253
(related)
|
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00017 | Esophageal cancer |
P35354
(related)
|
H00046 | Cholangiocarcinoma |
P35354
(related)
|
H00408 | Type I diabetes mellitus |
Q04759
(related)
|